Appreciate the response and have looked through the trial link. Have read a lot of trial data. Stayed up all night for 9-1 vote. this also led me to sell as that was smelly too.....especially the Dr of Indian decent that had no idea why she was in the room and asked ridiculous questions.
saying "you cant look at mortality stats" across the board I do not accept. If MSB is to be a successful commercial operation their drugs need to give you a better outcome than competitors or no treatment, Japanese patients have forked out anywhere from $10 - $100 million (from above posts). There is no approved treatment in the US for gvhd u/12.
Forget trials, studies, endpoints, single arm, blind, double blind SURELY Japanese kids have a better chance of survival than US kids with so much of the product being sold.
Not being a naysayer, downramper etc, I want MSB to be successful but this has urked me for years
- Forums
- ASX - By Stock
- MSB
- Growing doubt on COVID-19 Application
Growing doubt on COVID-19 Application, page-3349
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.46 |
Change
0.065(4.66%) |
Mkt cap ! $1.667B |
Open | High | Low | Value | Volume |
$1.41 | $1.50 | $1.40 | $5.699M | 3.943M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 122380 | $1.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.46 | 11015 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 119380 | 1.455 |
6 | 70073 | 1.450 |
5 | 55801 | 1.445 |
2 | 15656 | 1.440 |
2 | 37476 | 1.435 |
Price($) | Vol. | No. |
---|---|---|
1.460 | 11015 | 2 |
1.465 | 14833 | 2 |
1.470 | 49768 | 5 |
1.475 | 66248 | 3 |
1.480 | 37374 | 4 |
Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
3DA
AMAERO INTERNATIONAL LTD
Hank Holland, Executive Chairman and CEO
Hank Holland
Executive Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online